publishedDate,primaryTaxonomy.label,title,uri
2022-02-11T16:58:40Z,MedTech,Dexcom bests its ‘best year ever’ with 27% surge to $2.5B revenue in 2021,https://www.fiercebiotech.com/medtech/dexcom-bests-its-best-year-ever-27-surge-to-2-5b-revenue-2021
2022-02-11T15:40:24Z,Biotech,ProQR shares plummet as eye disease treatment flops phase 2/3 pediatric trial,https://www.fiercebiotech.com/biotech/proqr-treatment-for-congenital-eye-disease-kids-flops-phase-2-3-trial-shares-plummet-to-new
2022-02-11T14:39:14Z,MedTech,Senseonics lands long-awaited FDA approval for 6-month implanted CGM system,https://www.fiercebiotech.com/medtech/senseonics-lands-long-awaited-fda-approval-for-6-month-implanted-cgm-system
2022-02-11T14:34:17Z,Biotech,Cassava scores a win as FDA declines to intervene in petition to stop its Alzheimer's drug trials,https://www.fiercebiotech.com/biotech/cassava-scores-a-win-as-fda-denies-citizen-petition-over-data-manipulation-allegations-for
